Loading...
Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir
Raltegravir is a recently, Food and Drug Administration-approved, small-molecule drug that inhibits retroviral integrase, thereby preventing HIV DNA from inserting itself into the human genome. We report here that the activity profile of raltegravir on the replication of murine leukemia virus is sim...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2791572/ https://ncbi.nlm.nih.gov/pubmed/19923437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0908074106 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|